08
October 2024
Past Event
Do Drug Patents Cause High Drug Prices?

Event will air on this page.

 

Inquiries: msnow@hudson.org

Do Drug Patents Cause High Drug Prices?

Past Event
Online Only
October 08, 2024
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
Caption
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
08
October 2024
Past Event

Event will air on this page.

 

Inquiries: msnow@hudson.org

Speakers:
Adam Mossoff
Adam Mossoff

Chair, Forum for Intellectual Property and Senior Fellow

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law
Erika Lietzan

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law

Vice President and Global Head of Intellectual Property Affairs, Novartis
Corey A. Salsberg

Vice President and Global Head of Intellectual Property Affairs, Novartis

Moderator:
hartline
Devlin Hartline

Senior Fellow

For the past decade, policy activists have argued that drug innovators artificially extend the length of their exclusive patent protections on their drugs solely to keep drug prices high. One activist organization, the Initiative for Medicines, Access, and Knowledge (I-MAK), alleges that as many as 50 patents currently protect drugs from generic competition. 

But are I-MAK’s patent numbers correct? A 2022 Hudson policy memo, “How Unreliable Data Has Infected the Policy Debate Over Drug Patents,”detailed how I-MAK’s patent numbers contradict the number of drug patents listed in the Orange Book, the Food and Drug Administration’s official database of drug patents. Academic scholars have also done rigorous empirical studies, and the United States Patent and Trademark Office (USPTO) released its own empirical study in June 2024. Neither the USPTO nor the academic studies could replicate or confirm activist organizations’ patent numbers. Yet I-MAK’s claims continue to drive legislative proposals and agency actions.

Join Hudson for an expert discussion on the state of play concerning the empirical evidence on the connection between drug patents and drug prices and whether officials are engaging in evidence-based policymaking on this pressing concern.

Related Events
23
October 2025
In-Person Event | Invite Only
The US in the South Caucasus: Mapping New Strategic Opportunities 
Featured Speakers:
Ilan Berman
Luke Coffey
Steve Daines
Michael Doran
Ambassador Khazar Ibrahim
Efgan Nifti
Joel Scanlon
: President Donald Trump, Azerbaijani President Ilham Aliyev, and Armenian Prime Minister Nikol Pashinyan sign a joint declaration at the White House in Washington DC, on August 8, 2025. (Getty Images)
23
October 2025
In-Person Event | Invite Only
The US in the South Caucasus: Mapping New Strategic Opportunities 

A keynote address by Senator Steve Daines (R-MT), to examine the implications of the recent Armenia-Azerbaijan peace agreement. 

: President Donald Trump, Azerbaijani President Ilham Aliyev, and Armenian Prime Minister Nikol Pashinyan sign a joint declaration at the White House in Washington DC, on August 8, 2025. (Getty Images)
Featured Speakers:
Ilan Berman
Luke Coffey
Steve Daines
Michael Doran
Ambassador Khazar Ibrahim
Efgan Nifti
Joel Scanlon
30
October 2025
In-Person Event | Hudson Institute
How Long Can Russia’s Weakening Economy Support Putin’s War on Ukraine?
Featured Speakers:
Dr. Volodymyr Lugovskyy
Dr. Anders Aslund
Thomas J. Duesterberg
Getty Images
30
October 2025
In-Person Event | Hudson Institute
How Long Can Russia’s Weakening Economy Support Putin’s War on Ukraine?

Join noted Russian and Ukrainian economists and Hudson Senior Fellow Thomas Duesterberg for an event that will analyze how growing economic problems are affecting Vladimir Putin’s war effort and its ability to avoid an economic crisis.

Getty Images
Featured Speakers:
Dr. Volodymyr Lugovskyy
Dr. Anders Aslund
Thomas J. Duesterberg
03
November 2025
In-Person Event | Hudson Institute
Congressman Rich McCormick on Securing American AI Leadership
Featured Speakers:
Congressman Rich McCormick
Jason Hsu
Representative Rich McCormick speaks during a House Committee on Foreign Affairs hearing on January 11, 2024. (Getty Images)
03
November 2025
In-Person Event | Hudson Institute
Congressman Rich McCormick on Securing American AI Leadership

Senior Fellow Jason Hsu will host Congressman Rich McCormick (R-GA), a member of the House Armed Services Committee and Foreign Affairs Committee and a former member of the bipartisan Task Force on Artificial Intelligence, for a conversation on securing American AI leadership.

Representative Rich McCormick speaks during a House Committee on Foreign Affairs hearing on January 11, 2024. (Getty Images)
Featured Speakers:
Congressman Rich McCormick
Jason Hsu
04
November 2025
In-Person Event | Hudson Institute
Bad Money: How America Can Solve Perpetual Inflation
Featured Speakers:
Brendan Brown
Alex J. Pollock
Moderator:
Harold Furchtgott-Roth
Getty Images
04
November 2025
In-Person Event | Hudson Institute
Bad Money: How America Can Solve Perpetual Inflation

At Hudson, Senior Fellows Brendan Brown and Harold Furchtgott-Roth and Mises Institute Senior Fellow Alex Pollock will discuss the book’s findings and how gold-based monetary reform combined with the increased use of modern analytical tools can help end the inflationary spiral.

Getty Images
Featured Speakers:
Brendan Brown
Alex J. Pollock
Moderator:
Harold Furchtgott-Roth